KR20010010761A - beta chitin which is water-soluble without skin-trouble and viscosity-regulated and the cosmetics comprising it - Google Patents
beta chitin which is water-soluble without skin-trouble and viscosity-regulated and the cosmetics comprising it Download PDFInfo
- Publication number
- KR20010010761A KR20010010761A KR1019990029816A KR19990029816A KR20010010761A KR 20010010761 A KR20010010761 A KR 20010010761A KR 1019990029816 A KR1019990029816 A KR 1019990029816A KR 19990029816 A KR19990029816 A KR 19990029816A KR 20010010761 A KR20010010761 A KR 20010010761A
- Authority
- KR
- South Korea
- Prior art keywords
- chitin
- water
- beta chitin
- beta
- soluble
- Prior art date
Links
- 229920002101 Chitin Polymers 0.000 title claims abstract description 164
- 239000002537 cosmetic Substances 0.000 title claims abstract description 19
- 230000001105 regulatory effect Effects 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 114
- 239000003513 alkali Substances 0.000 claims abstract description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims abstract description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000011780 sodium chloride Substances 0.000 claims abstract description 11
- 238000005406 washing Methods 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- 206010040880 Skin irritation Diseases 0.000 abstract description 13
- 230000036556 skin irritation Effects 0.000 abstract description 13
- 231100000475 skin irritation Toxicity 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 241000238366 Cephalopoda Species 0.000 abstract description 5
- 239000002245 particle Substances 0.000 abstract description 5
- 239000002244 precipitate Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract 2
- 238000002791 soaking Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 26
- 239000012467 final product Substances 0.000 description 11
- 230000035484 reaction time Effects 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000004909 Moisturizer Substances 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000220259 Raphanus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 231100000067 mild irritant Toxicity 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 231100000323 severe irritant Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02P—CONTROL OR REGULATION OF ELECTRIC MOTORS, ELECTRIC GENERATORS OR DYNAMO-ELECTRIC CONVERTERS; CONTROLLING TRANSFORMERS, REACTORS OR CHOKE COILS
- H02P1/00—Arrangements for starting electric motors or dynamo-electric converters
- H02P1/02—Details of starting control
- H02P1/04—Means for controlling progress of starting sequence in dependence upon time or upon current, speed, or other motor parameter
- H02P1/08—Manually-operated on/off switch controlling power-operated multi-position switch or impedances for starting a motor
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05F—SYSTEMS FOR REGULATING ELECTRIC OR MAGNETIC VARIABLES
- G05F1/00—Automatic systems in which deviations of an electric quantity from one or more predetermined values are detected at the output of the system and fed back to a device within the system to restore the detected quantity to its predetermined value or values, i.e. retroactive systems
- G05F1/10—Regulating voltage or current
- G05F1/46—Regulating voltage or current wherein the variable actually regulated by the final control device is dc
- G05F1/468—Regulating voltage or current wherein the variable actually regulated by the final control device is dc characterised by reference voltage circuitry, e.g. soft start, remote shutdown
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- General Physics & Mathematics (AREA)
- Radar, Positioning & Navigation (AREA)
- Automation & Control Theory (AREA)
- Power Engineering (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 피부자극이 없으면서 점도가 조절된 수용성 베타키틴 및 이를 포함하는 화장료에 관한 것이다. 더욱 자세하게는, 피부자극이 없는 수용성 베타키틴을 준비하기 위해, 베타키틴을 40%이상의 수산화나트륨 수용액과 10℃이하에서 교반하는 단계 및 0℃이하에서 24시간이상 보관하는 단계를 포함하는 방법에 의해 수용성 베타키틴의 중간물질인 알칼리 베타키틴을 준비하는 것에 관한 것이다. 또한, 화장료에 적합한 점도를 갖는 수용성 베타키틴을 준비하기 위해, 본 발명에 따른 알칼리 베타키틴을 모노클로로아세트산과 반응시키되, 정제된 베타키틴에 대한 모노클로로아세트산의 투입비율을 3∼7(g/g)로 하여 제조된 수용성 베타키틴에 관한 것이다.The present invention relates to a water-soluble beta chitin and a cosmetic comprising the same, the viscosity is adjusted without the skin irritation. More specifically, in order to prepare a water-soluble beta chitin without skin irritation, the method comprising the step of stirring the beta chitin at 40 ℃ or more aqueous sodium hydroxide solution below 10 ℃ and storing below 0 ℃ 24 hours or more The present invention relates to the preparation of alkaline beta chitin, an intermediate of water-soluble beta chitin. In addition, in order to prepare a water-soluble beta chitin having a viscosity suitable for cosmetics, the alkali beta chitin according to the present invention is reacted with monochloroacetic acid, the ratio of monochloroacetic acid to purified beta chitin is 3-7 (g / It relates to a water-soluble beta chitin prepared as g).
키틴(chitin)은 아미노당(당의 아미노 유도체)으로 이루어진 다당류로서, N-아세틸글루코사민이 β-1,4 결합으로 중합된 것이다. 키틴은 백색분말로 물에 녹지 않고 반응성이 빈약하며, 셀룰로오즈와 비슷한 화학구조를 갖고 있으나 셀룰로오즈보다도 안정하다.Chitin is a polysaccharide composed of amino sugars (amino derivatives of sugars) in which N-acetylglucosamine is polymerized by β-1,4 bonds. Chitin is a white powder, insoluble in water and poorly reactive. It has a chemical structure similar to cellulose but is more stable than cellulose.
키틴은 절지동물의 딱딱한 표피나 껍데기의 골격을 만들 뿐만 아니라 곰팡이의 세포벽의 중요한 구성요소이다. 지구상의 키틴 존재량은 놀랄 만큼 많고, 갑각류의 한 무리인 개각목(介脚目)의 동물만으로도 1년간에 수천억 톤의 키틴을 생산하고 있다.Chitin is an important component of the cell walls of fungi, as well as building the hard epidermis or shell of arthropods. The amount of chitin present on the planet is surprisingly high, and even a single group of crustaceans, the kelp, produces hundreds of billions of tons of chitin a year.
예전에는 갑각류의 껍질등에 붙어있는 단백질이 부패하여 악취를 낼 뿐만 아니라 키틴분자간의 강한 수소결합으로 인하여 용해성이 좋지 않아 산업폐기물로 취급되어 왔으나, 최근에는 그 폐기물들이 여러 분야에서 소재로 주목을 받아 폐기물 처리문제와 자원의 이용면에서 키틴에 대한 많은 연구가 진행 중에 있다(Seichi Kataoka, Kobunshi Ronbunshu, 39,759(1982), S.Hattori, etal J. Colloid and Interface Sci. 104, 72(1985) 참조).In the past, proteins attached to the shells of crustaceans were not only odorous due to decay, but also were treated as industrial waste due to their poor solubility due to strong hydrogen bonds between chitin molecules. Much research has been done on chitin in terms of processing issues and resource use (see Seichi Kataoka, Kobunshi Ronbunshu, 39,759 (1982), S. Hattori, et al J. Colloid and Interface Sci. 104, 72 (1985)).
한편, 현재 화장품의 보습제로 사용되는 물질들은 단지 보습제로서의 기능만 있을 뿐 다른 기능이 없는 것이 대부분이다. 특히, 현재 화장품의 대표적인 보습제로 사용되고 있는 하이알루론산(hyaluronic acid)은 동,식물계에 널리 분포되어 있으나, 보습제 이외의 효능은 없는 것으로 알려져 있다.On the other hand, the materials currently used as moisturizers in cosmetics are mostly only functions as a moisturizer and no other functions. In particular, hyaluronic acid (hyaluronic acid), which is currently used as a representative moisturizer of cosmetics, is widely distributed in animal and plant systems, but it is known that there is no effect other than the moisturizer.
키틴은, 하이알루론산과 같이, 생체친화적인 고분자 물질로서, 용액의 상태에서 피부에 도포될 경우 필름을 형성함과 동시에 분자내에 하이드록실기를 함유하고 있기 때문에 피부의 수분손실을 최소화함으로서 보습기능을 나타낸다. 더욱이, 베타키틴은 알파키틴과 달리, 상처치유, 세포재생, 면역기능활성화의 생리활성기능이 우수한 것으로 보고되고 있다(Vaccine vol.4, 151-156(1986), Carbohydrate Res. vol.146,251-258(1986), 미국특허 제4,427,654호, 미국특허 제 5,698,228호 참조).Chitin, like hyaluronic acid, is a biocompatible polymer, which forms a film when it is applied to the skin in solution, and also contains hydroxyl groups in the molecule, thus exhibiting a moisturizing function by minimizing moisture loss in the skin. . In addition, beta chitin has been reported to have superior physiological activity in wound healing, cell regeneration, and immune function activation, unlike alpha chitin (Vaccine vol. 4, 151-156 (1986), Carbohydrate Res. Vol. 146,251-258). (1986), US Pat. No. 4,427,654, US Pat. No. 5,698,228).
그러나, 현재까지는 상기와 같이 우수한 기능을 갖는 베타키틴을 피부자극 없는 화장료로서 개발된 예는 없었다.However, until now, there has been no case in which beta chitin having excellent function as described above has been developed as a cosmetic without skin irritation.
따라서, 본 발명은, 피부생리활성이 우수한 베타키틴을 화장료에 적합한 기능성 원료로 개발하고자 한다. 즉, 물에 불용성인 베타키틴을 화장료 원료로 적합하도록 수용화시키되, 피부자극을 유발하지 않도록 수용화과정을 개발하고, 베타키틴의 물성을 적합하게 조절하여 본래의 베타키틴의 여러 효능을 그대로 보유함과 동시에 피부도포시 보습감을 향상시키고자 한다.Therefore, the present invention is to develop beta chitin excellent in skin physiological activity as a functional raw material suitable for cosmetics. In other words, the water-insoluble beta chitin is solubilized to be suitable as a cosmetic ingredient, but the solubility process is developed so as not to cause skin irritation, and the properties of beta chitin are properly adjusted to retain various effects of the original beta chitin. At the same time, to improve the moisturizing feeling when applying the skin.
본 발명은 피부자극이 없으면서 점도가 조절된 수용성 베타키틴 및 이를 포함하는 화장료에 관한 것이다. 더욱 자세하게는, 피부자극이 없는 수용성 베타키틴을 준비하기 위해, 베타키틴을 40%이상의 수산화나트륨 수용액과 10℃이하에서 교반하는 단계 및 0℃이하에서 24시간이상 보관하는 단계를 포함하는 방법에 의해 수용성 베타키틴의 중간물질인 알칼리 베타키틴을 준비하는 것에 관한 것이다. 또한, 화장료에 적합한 점도를 갖는 수용성 베타키틴을 준비하기 위해, 본 발명에 따른 알칼리 베타키틴을 모노클로로아세트산과 반응시키되, 정제된 베타키틴에 대한 모노클로로아세트산의 투입비율을 3∼7(g/g)로 하여 제조된 수용성 베타키틴에 관한 것이다.The present invention relates to a water-soluble beta chitin and a cosmetic comprising the same, the viscosity is adjusted without the skin irritation. More specifically, in order to prepare a water-soluble beta chitin without skin irritation, the method comprising the step of stirring the beta chitin at 40 ℃ or more aqueous sodium hydroxide solution below 10 ℃ and storing below 0 ℃ 24 hours or more The present invention relates to the preparation of alkaline beta chitin, an intermediate of water-soluble beta chitin. In addition, in order to prepare a water-soluble beta chitin having a viscosity suitable for cosmetics, the alkali beta chitin according to the present invention is reacted with monochloroacetic acid, the ratio of monochloroacetic acid to purified beta chitin is 3-7 (g / It relates to a water-soluble beta chitin prepared as g).
베타키틴을 화장료로 응용하기 위해서는 제형내에서 용해가능한 형태의 베타키틴을 준비하는 것이 바람직하다. 따라서, 본 발명은, 제형 중 가장 많은 부분인 수상에 용해될 수 있는 수용성 베타키틴을 준비하고자 한다.In order to apply beta chitin to cosmetics, it is preferable to prepare beta chitin in a soluble form in the formulation. Accordingly, the present invention seeks to prepare a water soluble beta chitin that can be dissolved in the aqueous phase, the largest portion of the formulation.
즉, 본 발명은 베타키틴을 화장료에 적용하기 위해, 먼저 천연물로부터 정제된 베타키틴(화학식 1)을, 6번 탄소에 위치한 수소가 수산화나트륨의 나트륨기로 치환된 알칼리 베타키틴(화학식 2)으로 전환시키고, 이러한 알칼리 베타키틴의 나트륨기를 카르복시메틸기로 치환시켜 수용성 베타키틴인 카르복시메틸베타키틴(화학식 3)을 제공하고자 한다. 이러한 카르복시메틸베타키틴은 친수성이 증가되어 수용성 성질을 띄게 된다.That is, in the present invention, in order to apply beta chitin to cosmetics, first, beta chitin (formula 1) purified from natural products is converted to alkali beta chitin (Formula 2) in which hydrogen located at carbon 6 is substituted with sodium group sodium hydroxide. Then, the sodium group of the alkali beta chitin is substituted with a carboxymethyl group to provide carboxymethyl beta chitin (Formula 3) which is a water-soluble beta chitin. Such carboxymethyl beta chitin has increased hydrophilicity to exhibit water-soluble properties.
아래에서는 베타키틴을 정제하는 과정, 정제된 천연의 베타키틴을 알칼리 베타키틴으로 전환시키는 과정 및 알칼리키틴을 수용성 베타키틴으로 만드는 과정으로 나누어, 본 발명을 상세히 설명하고자 한다.Hereinafter, the present invention will be described in detail by dividing the process of purifying beta chitin, converting the purified natural beta chitin into an alkali beta chitin, and making the alkali chitin into a water-soluble beta chitin.
[베타키틴의 정제][Betachitin Tablets]
수집된 오징어뼈(squid backbone)를 잘게 절단한 후 1∼3N의 수산화나트륨수용액에서 60∼90℃의 조건에서 1∼5시간동안 교반시켜 단백질을 제거한다. 그 다음 충분히 수세하여 수산화나트륨을 제거한 후, 상온에서 염산 0.1∼1N에 침적시켜 칼슘을 제거한다. 이때, 반응은 상온에서 수행하여야 키틴분자량의 감소를 막을 수 있다. 필요에 따라 이 과정을 2∼3회 실시한다.The collected squid backbone is finely cut and then stirred in 1 ~ 3N sodium hydroxide aqueous solution at 60 ~ 90 ° C. for 1 ~ 5 hours to remove the protein. Then, washed sufficiently with water to remove sodium hydroxide, and then deposited at 0.1 to 1 N hydrochloric acid at room temperature to remove calcium. At this time, the reaction should be performed at room temperature to prevent the reduction of the chitin molecular weight. If necessary, repeat this process two to three times.
특히, 고분자량의 수용성 키틴을 얻는 것이 바람직하므로, 본 발명에서는 염산의 농도를 0.1∼1N로 조절하며 온도를 상온으로 설정한다. 염산의 농도가 높고 온도가 높게 되면 베타키틴의 사슬이 파괴되어 분자량의 감소를 초래하기 때문이다.In particular, in order to obtain a high molecular weight water-soluble chitin, in the present invention, the concentration of hydrochloric acid is adjusted to 0.1 to 1N and the temperature is set to room temperature. This is because high concentrations of hydrochloric acid and high temperatures break down the chain of beta chitin, leading to a decrease in molecular weight.
한편, 정제된 베타키틴은 30이상의 메쉬(mesh)에 통과시키는 것이 바람직하며, 특히 30~40 메쉬에 통과시키는 것이 더욱 바람직하다. 베타키틴의 입자가 30메쉬보다 크게 되면, 알칼리 베타키틴 제조시 상대적으로 30메쉬보다 작은 입자에 비하여 나트륨기가 베타키틴의 6번 탄소의 수소와 충분히 치환하지 못하여 수용성 베타키틴으로의 치환이 이루어지지 않아 최종 생성물이 물에 잘 녹지 못한 콜로이드상태가 될 수 있기 때문이다.On the other hand, the purified beta chitin is preferably passed through more than 30 mesh (mesh), particularly preferably through 30-40 mesh. When the particles of beta chitin are larger than 30 mesh, the sodium group cannot be sufficiently substituted with the hydrogen of beta chitin 6 carbon in comparison with the particles smaller than 30 mesh in the production of alkali beta chitin. This is because the final product may become a colloidal state that is poorly soluble in water.
[알칼리 베타키틴의 제조][Preparation of Alkali Beta Chitin]
베타키틴을 알칼리 베타키틴으로 전환시키기 위해서는 베타키틴을 수산화나트륨 수용액과 반응시켜, 베타키틴의 6번 탄소에 위치한 수소를 수산화나트륨의 나트륨기로 치환시켜야 한다.To convert beta chitin into alkaline beta chitin, the beta chitin must be reacted with an aqueous sodium hydroxide solution to replace hydrogen located at carbon 6 of the beta chitin with the sodium group sodium hydroxide.
한편, 알칼리 베타키틴을 제조하는 종래방법[Vaccine vol. 4, 151-156(1986)]은, 키틴과 수산화나트륨수용액의 반응시 원활한 접촉을 갖게 하기 위해, 고농도의 수산화나트륨수용액에 0.1∼0.2%의 계면활성제인 소디움도데실설페이트를 첨가한다. 그러나 소디움도데실셀페이트는 최종 생성물에 잔존하게 되어 피부자극을 유발시키는 원인이 된다.On the other hand, the conventional method for producing an alkali beta chitin [Vaccine vol. 4, 151-156 (1986)] adds 0.1-0.2% of sodium dodecyl sulfate to a high concentration of sodium hydroxide solution in order to have a smooth contact during the reaction between chitin and sodium hydroxide solution. However, sodium dodecyl sulphate remains in the final product, causing skin irritation.
따라서, 본 발명에서는 알칼리 베타키틴 제조시 소디움도데실셀페트를 사용하지 아니하는 대신, 반응조건으로 10℃이하의 저온에서 수산화나트륨수용액에 베타키틴을 교반시킨 후, 24시간 이상 장시간 동안 0℃이하에서 방치한다[실험 3 참조].Therefore, in the present invention, instead of using sodium dodecyl selpet in the production of alkali beta chitin, the beta chitin was stirred in an aqueous sodium hydroxide solution at a low temperature of 10 ℃ or less as a reaction condition, and then at 0 ℃ or less for a long time more than 24 hours It is left (see Experiment 3).
교반시 반응온도를 10℃이하의 저온으로 유지시킨 이유는 고온에서는 수산화나트륨이 베타키틴의 아세틸아마이드기와 반응하여 아세틸기가 유리되면서 아민기로 전환된 키토산이 생성되기 때문이다. 반면, 저온에서는 수산화나트륨의 나트륨이온이 6번째의 탄소와 반응하여 알칼리 베타키틴이 생성된다.The reason why the reaction temperature was kept at a low temperature of 10 ° C. or lower during stirring was because sodium hydroxide reacts with the acetylamide group of the beta chitin to free the acetyl group, thereby producing chitosan converted to the amine group. On the other hand, at low temperatures, sodium ions of sodium hydroxide react with the sixth carbon to produce alkali beta chitin.
한편, 본 발명의 최종생산물인 수용성 베타키틴을 제조하기에 적합한 알칼리베타키틴 중간물을 제조하기 위해서, 수산화나트륨 수용액의 농도는 40%이상이어야 하며, 반응시간은 24시간이상이어야 한다[실험 2 참조]. 수산화나트륨 수용액의 농도가 40%이하이거나 반응시간이 24시간이하인 경우에는 본 발명의 알칼리 베타키틴이 형성되지 않기 때문이다. 또한, 같은 수산화나트륨 수용액의 농도에서도 반응시간에 따라 알칼리키틴의 수득률이 다르다. 바람직하게는 수산화나트륨의 농도는 50%이상, 반응시간은 48시간이상인 것이 좋다.On the other hand, in order to prepare an alkaline beta chitin intermediate suitable for preparing the final product of the present invention water-soluble beta chitin, the concentration of aqueous sodium hydroxide solution should be at least 40%, the reaction time should be at least 24 hours [see Experiment 2] ]. This is because the alkali beta chitin of the present invention is not formed when the concentration of the sodium hydroxide aqueous solution is 40% or less or the reaction time is 24 hours or less. In addition, the yield of alkali chitin is different depending on the reaction time even at the same concentration of sodium hydroxide aqueous solution. Preferably the concentration of sodium hydroxide is at least 50%, the reaction time is preferably at least 48 hours.
[수용성 베타키틴의 제조][Production of Water-soluble Beta Chitin]
본 발명에 따라 제조된 알칼리 베타키틴을 모노클로로아세트산과 반응시켜, 알칼리 베타키틴의 6번 탄소가 카르복시메틸기로 치환된 수용성 베타키틴을 제조한다.The alkali beta chitin prepared according to the present invention is reacted with monochloroacetic acid to prepare a water-soluble beta chitin in which carbon 6 of the alkali beta chitin is substituted with a carboxymethyl group.
이 때, 알칼리 베타키틴에 이소프로판올을 가하여 교반시키고, 모노클로로아세트산을 첨가하면, 카르복시메틸기로 치환된 수용성 베타키틴이 만들어진다. 이때, 반응열이 발생되므로 냉각수를 이용하여 온도를 10℃이하로 유지시켜야 한다.At this time, isopropanol is added to the alkali beta chitin and stirred, and monochloroacetic acid is added to form a water-soluble beta chitin substituted with a carboxymethyl group. At this time, since the heat of reaction is generated to maintain the temperature below 10 ℃ using cooling water.
정제된 베타키틴에 대하여 모노클로로아세트산의 비율은 3∼7(g/g)인 것이 바람직하다. 모토클로로아세트산의 첨가량에 따라 수용성 베타키틴의 점도가 달라지기 때문이다[실험 1 참조]. 정제된 베타키틴에 대하여 모노클로로아세트산의 비율이 3(g/g)이하인 경우는 수용성베타 키틴의 수득율이 저하된다. 즉, 비율이 3이상의 조건에서는 대개 80%의 수득율을 나타내지만, 3이하의 조건에서는 60∼70%로 급격히 수득율이 떨어지기 때문이다. 한편, 정제된 베타키틴에 대하여 모노클로로아세트산의 비율이 7(g/g)이상이면, 점도가 400∼350cps로 거의 일정한 값을 갖는다. 따라서, 모노클로로아세트산의 비율이 7이상으로 첨가하는 것은 무의미하고 비효율적이며, 이 경우에는 염 생성이 발생되어 피부 자극을 유발시킬 수 있는 문제점도 있다.The ratio of monochloroacetic acid to purified beta chitin is preferably 3 to 7 (g / g). This is because the viscosity of the water-soluble beta chitin varies depending on the amount of motochloroacetic acid added (see Experiment 1). When the ratio of monochloroacetic acid to purified beta chitin is 3 (g / g) or less, the yield of water-soluble beta chitin is lowered. In other words, the yield is usually 80% under the conditions of 3 or more, but the yield drops rapidly to 60 to 70% under the conditions of 3 or less. On the other hand, when the ratio of monochloroacetic acid to the purified beta chitin is 7 (g / g) or more, the viscosity is almost constant at 400 to 350 cps. Therefore, the addition of the ratio of monochloroacetic acid of 7 or more is insignificant and inefficient. In this case, there is a problem that salt formation may occur and cause skin irritation.
특히, 베타키틴에 대한 모노클로로아세트산의 비율은 4(g/g)인 것이 가장 바람직하다. 되도록 높은 점도를 띄는 것이 화장료에 적합한 사용감을 나타내기 때문이다.In particular, the ratio of monochloroacetic acid to beta chitin is most preferably 4 (g / g). This is because having a high viscosity as much as possible indicates a feeling of use suitable for cosmetics.
이 때, 이소프로판올을 첨가하는 이유는 다음과 같다. 첫째, 이소프로판올이 팽윤제의 역할을 하여, 알칼리 베타키틴이 팽윤됨으로써 모노클로로아세트산과의 반응을 원할하게 할 수 있다. 둘째, 키틴에 미량 존재하는 색소 및 단백질을 제거할 수 있다. 셋째, 알칼리 베타키틴과 수산화나트륨의 혼합물의 점도를 떨어뜨려 모노클로로아세트산과의 반응시 교반을 원할히 할 수 있다. 또한, 모노클로로아세트산은 이소프로판올 용액에서 용이하게 클로라이드와 아세트산으로 유리되기 때문에 쉽게 반응에 참여할 수 있다.At this time, the reason for adding isopropanol is as follows. First, isopropanol acts as a swelling agent, so that alkali beta chitin can be swollen to facilitate the reaction with monochloroacetic acid. Second, pigments and proteins present in trace amounts in chitin can be removed. Third, the viscosity of the mixture of alkali beta chitin and sodium hydroxide may be lowered to facilitate stirring during the reaction with monochloroacetic acid. In addition, monochloroacetic acid can easily participate in the reaction because it is easily released into chloride and acetic acid in isopropanol solution.
한편, 반응온도를 10℃이하로 유지시키는 이유는, 반응열로 인하여 키토산으로 전환되는 것을 막기위해서이다.On the other hand, the reason for maintaining the reaction temperature below 10 ° C is to prevent the conversion to chitosan due to the heat of reaction.
나아가, 상기와 같은 반응공정에 의해 제조된 수용성 베타키틴을 분리하고, 파우더로 만들기 위해, 다음과 같은 반응단계를 부가할 수 있다.Furthermore, to separate the water-soluble beta chitin prepared by the reaction process as described above and make it into a powder, the following reaction step may be added.
수용성 베타키틴을 제조하는 반응을 종결한 후, 원심분리기에 의해 탈수시켜 이소프로판올을 제거하고 에탄올을 가하여 교반한다. 이는 생성물의 형태가 덩어리진 형태이기 때문에 세척을 원활히 하기 위함이다.After the reaction to prepare the water-soluble beta chitin was terminated, dehydrated by centrifugation to remove isopropanol, and ethanol was added thereto and stirred. This is to facilitate the cleaning because the product is in the form of lumps.
그리고 나서, 충분히 세척한 후 생성물을 물에 용해시킨다. 완전히 용해시킨 후에 여과를 통해 불용분을 제거한 후, 2∼4%의 염화나트륨을 첨가하고, 여액에 1.5∼2배의 에탄올을 교반하면서 서서히 가하여 침전물을 얻는다. 이후 다시 에탄올을 이용하여 3회 세척을 한 후 진공건조를 하면 수용성 베타키틴을 파우더 상태로 분리할 수 있다.Then, after sufficient washing, the product is dissolved in water. After complete dissolution, the insolubles were removed by filtration, and then 2 to 4% of sodium chloride was added, and 1.5 to 2 times of ethanol was slowly added to the filtrate while stirring to obtain a precipitate. After washing three times with ethanol again and then vacuum-dried, water-soluble beta chitin can be separated into a powder state.
본 발명에 따라 제조된 수용성 베타키틴은 0.5%(w/v) 수용액 내지 1%(w/v) 수용액으로 제조하여(방부제 포함) 화장료에 적용할 수 있다.The water-soluble beta chitin prepared according to the present invention may be prepared from 0.5% (w / v) aqueous solution to 1% (w / v) aqueous solution (including preservatives) and applied to cosmetics.
아래에서는 실시예를 통해 본 발명을 상세히 설명하고자 하나, 본 발명은 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited to the following Examples.
[실시예 1; 베타키틴 정제][Example 1; Beta Chitin Tablet]
수집된 오징어뼈(squid backbone)를 커팅기를 사용하여 4∼5㎝정도의 크기로 잘랐다. 오징어뼈를 1N 수산화나트륨수용액에 침적시킨 후 약 90℃에서 1시간동안 교반하였다. 그리고 나서, 물로 충분히 수세하여 수산화나트륨을 제거하고 난 후 상온에서 희석된 1N 염산에 약 1시간동안 다시 교반시켰다.Collected squid backbone (squid backbone) was cut to a size of about 4 ~ 5cm using a cutter. Squid bone was immersed in 1N aqueous sodium hydroxide solution and stirred at about 90 ° C for 1 hour. Then, washed with water sufficiently to remove sodium hydroxide and stirred again for about 1 hour in 1N hydrochloric acid diluted at room temperature.
다시 물로 충분히 수세를 한 후 1N 수산화나트륨수용액에서 90℃, 1시간동안 교반하였다. 그리고 나서, 물로 충분히 수세한 후 건조하여, 단백질과 칼슘이 제거된 순수한 베타키틴입자를 얻었다.After washing sufficiently with water again, the mixture was stirred for 1 hour at 90 DEG C in 1N aqueous sodium hydroxide solution. Then, the mixture was washed with water sufficiently and dried to obtain pure beta chitin particles from which proteins and calcium were removed.
[실시예 2; 알칼리 베타키틴 제조][Example 2; Alkali beta chitin production]
실시예 1에서 정제된 베타키틴을 분쇄하여 30메쉬를 통과시켰다. 그 결과로 나온 베타키틴입자 10g을 50%(w/v)농도의 수산화나트륨수용액 100ml에 첨가하고 나서, 온도를 10℃이하로 유지하면서 교반하였다. 약 1시간정도 교반한 후 0℃이하의 냉동실에서 하루정도 보관하였다. 그러면, 6번 탄소의 수소가 나트륨기로 치환된 알칼리 베타키틴을 수득할 수 있다.Purified beta chitin in Example 1 was ground and passed through 30 mesh. 10 g of the resulting beta chitin particles were added to 100 ml of an aqueous sodium hydroxide solution at a concentration of 50% (w / v), followed by stirring while maintaining the temperature at 10 ° C or lower. After stirring for about 1 hour and stored in a freezer at 0 ℃ or less for one day. Then, an alkali beta chitin in which hydrogen of carbon 6 is substituted with a sodium group can be obtained.
[실시예 3; 수용성 베타키틴의 제조][Example 3; Preparation of Water Soluble Beta Chitin]
실시예 2에 의해 제조된 슬러리 상태의 알칼리 베타키틴에 이소프로판올 1ℓ를 가하여 충분히 섞이도록 교반하였다. 그리고 나서, 모노클로로아세트산 40g을 첨가하였다. 이 때, 반응열이 발생되므로 냉각수를 이용하여 온도를 10℃이하로 유지시켰다. 이로인해, 카르복시메틸기가 키틴의 6번 탄소와 결합한 수용성 베타키틴이 제조되었다.1 L of isopropanol was added to the alkaline beta chitin in the slurry prepared in Example 2, followed by stirring to sufficiently mix. Then 40 g of monochloroacetic acid was added. At this time, since heat of reaction was generated, the temperature was maintained at 10 ° C. or lower using cooling water. This produced a water-soluble beta chitin in which a carboxymethyl group was bonded to carbon 6 of chitin.
반응 종결 후 이소프로판올을 제거하고, 에탄올을 약 0.5ℓ 가하여 교반하였다. 그리고 나서, 충분히 세척을 한 후 생성물을 물에 용해시켰다. 완전히 용해시킨 후, 여과를 통해 불용분을 제거한 후 4%의 염화나트륨을 첨가하고, 여액의 1.5배 에탄올을 교반하면서 서서히 가하여 침전물을 얻었다. 이후 다시 에탄올을 이용하여 3회 세척을 한 후 진공건조를 하여 카르복시메틸기가 치환된 수용성 베타키틴을 분리하였다.After completion of the reaction, isopropanol was removed, and about 0.5 L of ethanol was added and stirred. Then, after sufficient washing, the product was dissolved in water. After complete dissolution, the insolubles were removed by filtration, and then 4% sodium chloride was added, and 1.5 times ethanol of the filtrate was slowly added with stirring to obtain a precipitate. After washing three times with ethanol again, and vacuum-dried to separate the water-soluble beta chitin substituted carboxymethyl group.
〈실험 1; 수용성 베타키틴의 점도 측정〉<Experiment 1; Viscosity Measurement of Water Soluble Betachitin>
1) 정제된 베타키틴을 분쇄하여 30메쉬를 통과시킨 후, 10g의 정제된 베타키틴을 50%(w/v) 수산화나트륨수용액에 침적시켜 -1℃에서 24시간이상 동안 보관하여, 알칼리 베타키틴으로 전환시켰다.1) After pulverizing the purified beta chitin and passing through 30 mesh, 10 g of purified beta chitin was deposited in 50% (w / v) sodium hydroxide solution and stored at -1 ° C. for at least 24 hours, and alkali beta chitin Switched to
2) 이소프로판올 1ℓ를 가하여 충분히 교반하고 나서, 각 샘플에 각각 모노클로로아세트산 30g,40g,50g,70g을 투입하여 반응시켰다.2) After adding 1 L of isopropanol and stirring it sufficiently, 30 g, 40 g, 50 g, and 70 g of monochloroacetic acid were added to each sample for reaction.
3) 반응 완결 후 각각의 샘플을 0.5ℓ 에탄올에 가하여 교반한 후 이온수에 완전 용해시키고 4% 염화나트륨을 가하였다. 이에 에탄올을 1.5배의 부피로 서서히 가하여 침전물을 얻었다. 이를 다시 에탄올로 3회 세척한 후 여과, 건조하여 최종 생성물인 수용성 베탄키틴을 수득하였다.3) After completion of the reaction, each sample was added to 0.5 L ethanol, stirred, completely dissolved in deionized water, and 4% sodium chloride was added thereto. Ethanol was slowly added to a volume of 1.5 times to obtain a precipitate. This was again washed three times with ethanol, filtered and dried to obtain the final product, water-soluble betanchitin.
4) 각각의 최종생성물에서 샘플링을 하여 0.5%(w/v) 수용액을 제조한 후 점도계(Brrokfield점도계, spindle NO.2, RPM30)를 이용하여 점도를 측정하였다. 그 결과는 표 1에 나타나 있다.4) After preparing the 0.5% (w / v) aqueous solution by sampling each final product, the viscosity was measured using a viscometer (Brrokfield viscometer, spindle NO.2, RPM30). The results are shown in Table 1.
위의 상기 표 1에 나타난 결과와 같이, 모노클로로아세트산의 투입비율을 조절함으로써 생성되는 수용성 베타키틴의 점도를 조절할 수 있다. 베타키틴 10g에 대하여 모노클로로아세트산의 양이 40g일 때 점도가 가장 높았다. 따라서, 본 발명에서는 화장료에 적합한 원료로써 점도가 높은 수용성 베타키틴의 제조를 위해 베타키틴과 모노클로로아세트산의 비율을 1:4로 조절하고자 한다.As shown in Table 1 above, it is possible to control the viscosity of the water-soluble beta chitin produced by adjusting the input ratio of monochloroacetic acid. The viscosity was the highest when the amount of monochloroacetic acid was 40 g with respect to 10 g of beta chitin. Therefore, the present invention intends to adjust the ratio of beta chitin and monochloroacetic acid to 1: 4 for the preparation of water-soluble beta chitin with high viscosity as a raw material suitable for cosmetics.
한편, 베타키틴 10g에 대하여 모노클로로아세트산의 양을 30g이하로 한 경우에는, 수용성베타 키틴의 수득율이 저하되었다. 즉, 30g이상의 조건에서는 대개 80%의 수득율을 나타내지만, 30g이하의 조건에서는 60∼70%로 급격히 수득율이 떨어졌다. 따라서, 알칼리베타키틴과 충분한 반응을 하기위한 모노클로로아세트산의 최소양이 30g이다.On the other hand, when the amount of monochloroacetic acid was made 30 g or less with respect to 10 g of beta chitin, the yield of water-soluble beta chitin fell. In other words, the yield was usually 80% under the conditions of 30g or more, but rapidly decreased to 60-70% under the conditions of 30g or less. Therefore, the minimum amount of monochloroacetic acid for sufficient reaction with alkali beta chitin is 30 g.
또한, 베타키틴 10g에 대하여 모노클로로아세트산의 양을 70g이상으로 한 경우에는, 점도가 350∼400cps로 거의 일정한 값을 갖는다. 따라서, 모노클로로아세트산을 70g이상 첨가하는 것은 무의미하고 비효율적이며, 이 경우에는 염 생성이 발생되어 피부 자극을 유발시킬 수 있는 문제점도 있다.When the amount of monochloroacetic acid is 70 g or more with respect to 10 g of beta chitin, the viscosity is almost constant at 350 to 400 cps. Therefore, the addition of more than 70g of monochloroacetic acid is meaningless and inefficient, in this case, there is also a problem that can cause salt generation to cause skin irritation.
〈실험 2; 알칼리 베타키틴을 제조하기에 최적화된 수산화나트륨 수용액의 농도 및 반응시간〉<Experiment 2; Concentration and Reaction Time of Aqueous Sodium Hydroxide Solution for the Preparation of Alkali Betachitin>
10℃이하의 저온하에서 베타키틴을 수산화나트륨수용액과 반응시켜, 베타키틴의 6번 탄소에 위치한 수소를 나트륨기로 치환시킨 알칼리 키틴을 제조하였다.The beta chitin was reacted with an aqueous sodium hydroxide solution at a temperature lower than 10 ° C. to prepare an alkaline chitin in which hydrogen located at carbon 6 of the beta chitin was substituted with a sodium group.
아래 표 2에서와 같이, 수산화나트륨수용액의 농도 및 반응시간을 달리하여 실험함으로써, 최종 생산물인 수용성 베타키틴의 중간물질인 알칼리 키틴을 제조하는데 최적인 수산화나트륨수용액의 농도와 반응시간을 결정하고자 하였다.As shown in Table 2 below, by varying the concentration and reaction time of the sodium hydroxide aqueous solution, the concentration and reaction time of sodium hydroxide aqueous solution, which is optimal for preparing alkali chitin, an intermediate of water-soluble beta chitin, the final product, was determined. .
본 발명의 알칼리 키틴이 제조되었는지 여부는, 상기 알칼리 키틴과 모노클로로아세트산을 1:4의 비율로 조절하여 반응시킨 후 최종 생성물을 이온수에 녹인 후 용해 여부로써 판단하였다.Whether or not the alkaline chitin of the present invention was prepared was determined by dissolving the final product in ionized water after reacting the alkali chitin and monochloroacetic acid at a ratio of 1: 4.
( × : 반응 안됨, ○ : 반응 이루어짐 )(×: no reaction, ○: reaction)
상기 표 2의 결과를 살펴보면, 수산화나트륨수용액의 농도가 40%이하인 경우에는, 최종생산물인 수용성베타키틴의 중간물인 알칼리키틴이 형성되지 않는다는 것을 알 수 있다.Looking at the results of Table 2, it can be seen that when the concentration of the aqueous sodium hydroxide solution is less than 40%, alkali chitin is not formed as an intermediate of the water-soluble beta chitin as the final product.
수산화나트륨수용액의 농도가 50%, 60%일 때는 반응시간이 24시간, 48시간 일 때, 본 발명이 목적하는 알칼리키틴이 형성됨을 알 수 있었다.When the concentration of the aqueous sodium hydroxide solution is 50%, 60%, it can be seen that when the reaction time is 24 hours, 48 hours, the alkali chitin of the present invention is formed.
한편, 본 발명의 알칼리키틴의 최종 수득율은 24시간보다 48시간일 때 더 높았다. 이러한 점은 같은 농도에서도 반응시간에 따라서 생성되는 알칼리 키틴의 양이 다르기 때문일 것이라고 추측된다.On the other hand, the final yield of the alkali chitin of the present invention was higher at 48 hours than at 24 hours. This may be because the amount of alkali chitin produced varies depending on the reaction time even at the same concentration.
따라서, 알칼리키틴의 제조에 있어서는 수산화나트륨의 농도를 50%이상에서, 반응시간을 48시간이상 조절함이 바람직하다는 것을 알 수 있다.Therefore, in the production of alkali chitin, it can be seen that it is preferable to adjust the reaction time at a concentration of 50% or more and at least 48 hours.
〈실험 3; 피내(皮內)안정성(intradermal safty) 시험〉<Experiment 3; Intradermal safty test>
[비교예 1]Comparative Example 1
정제된 베타키틴을 분쇄하여 30메쉬(mesh)를 통과시켜 10g을 회수한 후, 0.2% 소디움도데실설페이트가 함유된 50% 수산화나트륨수용액 100㎖에 침적시켜 10℃이하에서 교반시킨 후, -1℃에서 12시간 보관하였다. 그리고 나서, 모노클로로아세트산 40g을 서서히 첨가시킨 후 교반하면서 반응을 진행시켰다. 이후 반응액을 냉장상태에서 24시간동안 보관한 후 에탄올을 가하여 반응물을 분산시킨 후 여과후 4%(w/v)염화나트륨수용액에 용해시켰다. 완전 용해시킨 후 에탄올을 용액부피의 1.5배까지 서서히 가하여 최종 생성물을 얻었다. 이후 여과하여 분리한 후 건조하여 파우더를 얻었다(시료 1).The purified beta chitin was pulverized and passed through a 30 mesh to recover 10 g, and then immersed in 100 ml of 50% sodium hydroxide aqueous solution containing 0.2% sodium dodecyl sulfate, stirred at 10 ° C. or less, and then -1. It was stored for 12 hours at ℃. Then, 40 g of monochloroacetic acid was slowly added, followed by stirring while stirring. Thereafter, the reaction solution was stored in a refrigerated state for 24 hours, ethanol was added thereto to disperse the reaction product, and then filtered and dissolved in an aqueous 4% (w / v) sodium chloride solution. After complete dissolution, ethanol was slowly added to 1.5 times the solution volume to obtain a final product. After filtration separated and dried to obtain a powder (sample 1).
[실시예 4]Example 4
정제된 베타키틴을 분쇄하여 30메쉬를 통과시켜 10g을 회수한 후, 50% 수산화나트륨 수용액 100㎖에 침적시켜 10℃이하에서 교반시킨 후 -1℃에서 48시간 보관하였다. 그리고 나서, 모노클로로아세트산 40g을 서서히 첨가시킨 후 교반하면서 반응을 진행시켰다. 이후 반응액을 냉장상태에서 24시간동안 보관한 후 에탄올을 가하여 반응물을 분산시키고, 여과한 후 4%(w/v) 염화나트륨수용액에 용해시켰다. 완전 용해된 후에는 에탄올을 용액부피의 1.5배까지 서서히 가하여 최종 생성물을 얻었다. 이후 여과하여 분리한 후 건조하여 파우더를 얻었다(시료 2).Purified beta chitin was pulverized and passed through 30 mesh to recover 10 g, and then immersed in 100 ml of 50% aqueous sodium hydroxide solution, stirred at 10 ° C. or less, and then stored at −1 ° C. for 48 hours. Then, 40 g of monochloroacetic acid was slowly added, followed by stirring while stirring. Thereafter, the reaction solution was stored in a refrigerated state for 24 hours, and then ethanol was added to disperse the reaction product, filtered, and dissolved in 4% (w / v) aqueous sodium chloride solution. After complete dissolution, ethanol was added slowly to 1.5 times the solution volume to obtain the final product. After filtration separated and dried to obtain a powder (sample 2).
위의 비교예 1 및 실시예 4에서 얻은 최종생성물 시료 1 및 2에 대하여 각각 피내(皮內)안정성(intradermal safty) 시험을 실시하였다.Intradermal safty tests were performed on the final product samples 1 and 2 obtained in Comparative Example 1 and Example 4, respectively.
시험방법은 다음과 같다.The test method is as follows.
1) 1% 에반스청(Evans blue) 4ml/kg을 토끼에 정맥 주사하였다.1) 4 ml / kg of 1% Evans blue was intravenously injected into rabbits.
2) 즉시, 0.1ml의 시료 1 또는 2를 피하 주사하고, 1시간 후에 치사시켰다.2) Immediately, 0.1 ml of sample 1 or 2 was injected subcutaneously and lethal after 1 hour.
3) 등 피부를 박리하고 검경하였다.3) The back skin was peeled off and examined.
그 결과는 표 3에 나타나 있다.The results are shown in Table 3.
* ( ) : 24시간 후의 반응* (): Reaction after 24 hours
판정기준Criteria
0-0.9 : 무자극(non-irritant), 1.0-1.9 : 경자극(slight irritant),0-0.9: non-irritant, 1.0-1.9: light irritant,
2.0-2.9 : 중자극(mild irritant), 3.0이상 : 강자극(severe irritant)2.0-2.9: Mild irritant, 3.0 and above: Severe irritant
n=1, n=2는 실험에 사용된 동물을 번호로 표시한 것임n = 1, n = 2 are numbers of animals used in the experiment
상기 표 3에서에서 알 수 있듯이, 종래의 방법에 따라 알칼리키틴을 제조할 때(비교예 1) 함유된 계면활성제 소디움도데실설페이트는 피부자극을 유발시킨다. 따라서, 본 발명은 실시예 4와 같이 계면활성제를 사용하지 않는 공정을 개발하였다. 즉, 실시예 4에서와 같이 저온에서 수산화나트륨수용액에 베타키틴을 교반시킨 후 장시간 동안 0℃이하에서 방치하면 계면활성제없이도 알칼리 베타키틴을 제조할 수 있다.As can be seen in Table 3, the surfactant sodium dodecyl sulfate contained when preparing the alkaline chitin according to the conventional method (Comparative Example 1) causes skin irritation. Accordingly, the present invention has developed a process using no surfactant as in Example 4. That is, as in Example 4, the beta chitin was stirred in an aqueous sodium hydroxide solution at low temperature, and then left at 0 ° C. or less for a long time to prepare alkali beta chitin without a surfactant.
본 발명에 의해 제조된 수용성 베타키틴은, 피부자극을 일으키지 아니하면서 수용성 성질을 갖게 되므로 화장료의 원료로 적합하며, 화장료에 적합한 점도를 갖도록 조절되었다.The water-soluble beta chitin prepared by the present invention has water-soluble properties without causing skin irritation, and thus is suitable as a raw material for cosmetics and has been adjusted to have a viscosity suitable for cosmetics.
또한, 본 발명에 의해 제조된 수용성 베타키틴은 본래의 베타키틴의 상처치유, 세포재생, 면역기능활성화 등 여러 효능을 그대로 보유함과 동시에 피부도포시 보습감을 향상시키고 있다.In addition, the water-soluble beta chitin prepared by the present invention retains various effects such as wound healing, cell regeneration, and immune function activation of the original beta chitin, and improves the moisturizing feeling during skin application.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990029816A KR100328974B1 (en) | 1999-07-22 | 1999-07-22 | Method for producing water-soluble beta chitin and the cosmetics comprising the beta chitin produced by the method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990029816A KR100328974B1 (en) | 1999-07-22 | 1999-07-22 | Method for producing water-soluble beta chitin and the cosmetics comprising the beta chitin produced by the method |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010010761A true KR20010010761A (en) | 2001-02-15 |
KR100328974B1 KR100328974B1 (en) | 2002-03-20 |
Family
ID=19603755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990029816A KR100328974B1 (en) | 1999-07-22 | 1999-07-22 | Method for producing water-soluble beta chitin and the cosmetics comprising the beta chitin produced by the method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100328974B1 (en) |
-
1999
- 1999-07-22 KR KR1019990029816A patent/KR100328974B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100328974B1 (en) | 2002-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hon | Cellulose and its derivatives: structures, reactions, and medical uses | |
US5536825A (en) | Derivatized guar gum composition and process for making it | |
US5489674A (en) | Guar gum composition and process for making it | |
US20100029929A1 (en) | Method of producing cross-linked polysaccharide particles | |
EP0988324B1 (en) | Method for manufacturing pure guar meal | |
JPH0353321B2 (en) | ||
JPH02138346A (en) | Crosslinked hyaluronic acid gel composition and its manufacture | |
EP0686643B1 (en) | Guar gum composition and process for making it | |
US8785622B2 (en) | Crosslinked polysaccharides and methods of production thereof | |
DE69021724T2 (en) | Modified protease, process for its preparation and cosmetic compositions containing it. | |
EP2044126B1 (en) | Method for making derivatized guar gum and derivatized guar gum made thereby | |
EP1250359A1 (en) | Chitosan condensation products, their preparation and their uses | |
CA2407584A1 (en) | Process for preparing chitosan particles | |
WO2009126256A2 (en) | Crosslinking method and crosslinked polysaccharide made thereby | |
WO2007026341A1 (en) | A method for preparing polyanhydroglucuronic acid and/or salts thereof | |
US6740752B2 (en) | Process for preparing chitosan particles | |
KR100328974B1 (en) | Method for producing water-soluble beta chitin and the cosmetics comprising the beta chitin produced by the method | |
CN1431227A (en) | Granule content of glucomannan glycering ester of konjak as well as its preparing method and usage | |
CN1401725A (en) | Cation guar gum | |
JP2529729B2 (en) | Method for producing chitosan derivative | |
JP3803123B2 (en) | Water-soluble partially deacetylated chitin and process for producing the same | |
JP3762234B2 (en) | Sulfated polysaccharide cross-linked with polycationic substance and process for producing the same | |
KR0144372B1 (en) | Water-soluble resin conjugated with chitin and cellulose and method for preparing same | |
KR980009287A (en) | Method for preparing high purity crystalline NOCC and method for controlling molecular weight of water soluble chitosan using enzyme | |
CN116925258A (en) | Preparation method of chitin highly dispersed in water phase and prepared chitin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20080222 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |